Literature DB >> 24239850

The incidence rate of prostate cancer in Saudi Arabia: an observational descriptive epidemiological analysis of data from the Saudi Cancer Registry 2001-2008.

Ibrahim G Alghamidi1, Issam I Hussain2, Mohamed S Alghamdi3, Mohammed A El-Sheemy4.   

Abstract

BACKGROUND: This study presents descriptive epidemiological data related to prostate cancer cases diagnosed from 2001 to 2008 among Saudi men, including the frequency and percentage of cases, the crude incidence rate (CIR) and the age-standardised incidence rate (ASIR) adjusted by region and year of diagnosis.
METHODS: This is a retrospective descriptive epidemiological analysis of all Saudi prostate cancer cases recorded in the Saudi Cancer Registry (SCR) between January 2001 and December 2008. Statistical analyses were conducted using descriptive statistics, the Poisson regression model, a simple linear regression model and analysis of variance with the Statistical Package for the Social Sciences version 20.0 (SPSS).
RESULTS: A total of 1739 cases were registered in the SCR between January 2001 and December 2008. The eastern region of Saudi Arabia had the highest overall ASIR at 10.1 per 100,000 men, followed by Riyadh at 7.1 and Makkah at 5.2, while Jizan and Najran had the lowest average ASIRs at 1.4 and at 2.0, respectively. The Poisson regression model for the region of Jizan shows that the incidence rate ratio (IRR) was significantly higher (p < 0.001); for the regions of Riyadh at 3.43 times (95% CI, 3.13-3.73), followed by Makkah at 2.56 (95% CI, 2.38-2.74) and the eastern province at 1.93 (95% CI, 1.64-2.23). The annual prediction of the CIR of prostate cancer in Saudi Arabia could be defined by the equation 1.53 + (0.094 × Years), and the prediction of the ASIR could be defined by the equation 2.98 + (0.182 × Years).
CONCLUSION: There was a steady increase in the CIRs and ASIRs for prostate cancer between 2001 and 2008. The eastern region, Riyadh and Makkah had the highest overall ASIR in Saudi Arabia. Further effective screening programmes and active treatment measures are needed to control prostate cancer disease among Saudi men.
Copyright © 2013 King Faisal Specialist Centre & Research Hospital. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Age standardised incidence rate; Crude incidence rate; Epidemiology; Prostate cancer; Saudi Cancer Registry

Mesh:

Year:  2013        PMID: 24239850     DOI: 10.1016/j.hemonc.2013.10.001

Source DB:  PubMed          Journal:  Hematol Oncol Stem Cell Ther


  17 in total

1.  Prostate cancer in Jordanian-Arab population: ERG status and relationship with clinicopathologic characteristics.

Authors:  Najla Aldaoud; Nour Abdo; Samir Al Bashir; Mohammad Alqudah; Noor Marji; Hiba Alzou'bi; Rami Alazab; Kiril Trpkov
Journal:  Virchows Arch       Date:  2017-05-26       Impact factor: 4.064

Review 2.  Individualized medicine enabled by genomics in Saudi Arabia.

Authors:  Muhammad Abu-Elmagd; Mourad Assidi; Hans-Juergen Schulten; Ashraf Dallol; Peter Pushparaj; Farid Ahmed; Stephen W Scherer; Mohammed Al-Qahtani
Journal:  BMC Med Genomics       Date:  2015-01-15       Impact factor: 3.063

Review 3.  With increasing trends of prostate cancer in the Saudi Arabia and Arab World: Should we start screening programs?

Authors:  Mostafa A Arafa; Danny M Rabah
Journal:  World J Clin Oncol       Date:  2017-12-10

4.  Fibrinogen and D-dimer levels in prostate cancer: Preliminary results.

Authors:  Selahattin Çalışkan; Mustafa Sungur
Journal:  Prostate Int       Date:  2017-05-19

5.  Epidemiology of senile prostatic enlargement among elderly men in Arar, Kingdom of Saudi Arabia.

Authors:  Abdullah Barghash Alanazi; Anfal Muaddi Alshalan; Omar Ayed Alanazi; Munif Salah Alanazi; Abdulaziz Inad Alanazi; Abdullah Hussain Alanazi; Anwar Mohammed Alhadhari; Ahmed Saad Alanazi; Rahmah Abdulhadi Alanazi; Ibtisam Matan Alanazi; Mohammed Abdullah Alanazi; Mohammed Abdullah Alkhidhr; Hassan Ali Aldehneen; Raed Khalid Alanazi
Journal:  Electron Physician       Date:  2017-09-25

6.  Development of two socioeconomic indices for Saudi Arabia.

Authors:  Reem S AlOmar; Roger C Parslow; Graham R Law
Journal:  BMC Public Health       Date:  2018-06-26       Impact factor: 3.295

7.  Incidence of prostate cancer among patients with prostate-related urinary symptoms: A single institution series in 10 years.

Authors:  Khalid M Alotaibi
Journal:  Urol Ann       Date:  2019 Apr-Jun

8.  Histopathological diagnoses and patterns in transrectal ultrasound-guided prostatic biopsy series from a large tertiary care center in Saudi Arabia.

Authors:  Ali A Alsulihem; Muaiqel Al-Muaiqel; Abdulrahman Alsunbul; Abdulrahman Bin Jawhar; Abdullah Al-Dughaiman; Khalid K Bedaiwi; Sami Al-Rashidi; Faris Al-Harbi; Hosam S El-Tholoth; Mohammad Al-Hagbani; Bader Milibary; Abdullah M Alghamdi
Journal:  Urol Ann       Date:  2020-11-04

9.  Prostatic diseases under focus in a university hospital in Eastern Saudi Arabia. A 15-year experience.

Authors:  Areej M Al Nemer; Reem B Aldamanhori
Journal:  Saudi Med J       Date:  2015-11       Impact factor: 1.484

10.  Prostate cancer screening in a low prevalence population. Is it worth it?

Authors:  Mostafa A Arafa; Karim H Farhat; Mohamed A Al-Atawi; Danny M Rabah
Journal:  Saudi Med J       Date:  2017-07       Impact factor: 1.484

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.